PUBLIC COMPANY
saveJOURNEY
USupdated 3mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Unknown
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- In Sudan, attacks on hospitals force patients to make dangerous journeysAmid a civil war in Sudan, it’s now difficult for people with cancer and other long-term illnesses to receive treatment that was once readily availablestat · 8h ago
- U.S. reaches highest number of measles deaths in decadesHow the midterms could change health care, the sedative contaminating the fentanyl black market, and other health news from Morning Roundsstat · 2d ago
- Opinion: How my cancer diagnosis changed the way I train physicians“The tumors, test results, and treatments I present to future physicians? Mine,” writes David Elkowitz, a professor of pathology and laboratory medicine and science education.stat · 2d ago
- Stakeholders urge FDA to define data, treatment standards as psychedelic drugs near marketSafety and access were top of mind at Monday’s public hearing exploring the regulation of psychedelic therapies. "The medicine opens the door,” NeuroAlchemy co-founder Michaela Vogt said during the…biospace · 3d ago
- Exercise — and echocardiograms — in space protected astronauts’ hearts in studyIf humans journey to Mars in 2035, exercise will be critical to keeping their hearts strong in microgravity.stat · 3d ago
- FDA places partial hold on Biohaven’s epilepsy drugAnnounced mere weeks after Biohaven sold off rights to the therapy, opakalim, the halt affects a study some analysts believe is necessary to support a potential approval.biopharma_dive · 8d ago
- Telemedicine company offers GLP-1s for addictionA CDC Covid restructuring, public trust in Fauci, and more health news from Morning Roundsstat · 9d ago
- Steady stream of crossover rounds stock biotech's IPO pipelineBiotech crossover rounds could top $4.22 billion across about 28 rounds this year, PitchBook forecasts.biospace · 9d ago
- AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPDWith a detailed data drop that AstraZeneca’s R&D chief describes as an internal “science success story,” the British Big Pharma has secured an FDA priority review for what it believes could become…fiercebiotech · 10d ago
- Can Benelux turn scientific strength into larger biotech scale?Belgium and the Netherlands have built some of Europe's strongest life sciences ecosystems, powered by leading research institutions and a growing pool of experienced biotech talent. While early-st…biospace · 10d ago
comments(0)
5-min edit window · permanent after that